How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials

BACKGROUND: Accurately characterizing a drug’s safety profile is essential. Trial harm and tolerability assessments rely, in part, on participants’ reports of medical histories, adverse events (AEs), and concomitant medications. Optimal methods for questioning participants are unclear, but different...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Elizabeth N, Mushi, Adiel K, Massawe, Isolide S, Vestergaard, Lasse S, Lemnge, Martha, Staedke, Sarah G, Mehta, Ushma, Barnes, Karen I, Chandler, Clare IR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832682/
https://www.ncbi.nlm.nih.gov/pubmed/24229315
http://dx.doi.org/10.1186/1471-2288-13-140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832682/
https://www.ncbi.nlm.nih.gov/pubmed/24229315
http://dx.doi.org/10.1186/1471-2288-13-140

Ejemplares similares